Nav: Home

Experts discuss real world use of PrEP for the prevention of HIV infection

December 14, 2015

Experts discuss real world use of PrEP for the prevention of HIV infection

'Beyond the Guidelines' features articles and videos exploring challenging clinical cases from Beth Israel Deaconess Medical Center Grand Rounds Sessions
Abstract: http://www.annals.org/article.aspx?doi=10.7326/M15-1993
URL live when embargo lifts

Evidence shows a substantial reduction in HIV transmission among patients receiving a daily combination of tenofovir and emtricitabine. As such, the U.S. Public Health Service recently recommended that physicians offer this daily combo as preexposure prophylaxis (PrEP) to patients at high risk for HIV infection, including nonmonogamous men who have sex with men, serodiscordant couples, heterosexual men and women in other risk groups, and injection drug users.

While the guidelines are clear, their application in clinical practice might present challenges based on individual patient characteristics. A multicomponent article published in Annals of Internal Medicine goes 'Beyond the Guidelines' to debate the use of PrEP in a 45-year old man whose husband has HIV infection with an undetectable viral load on treatment.

Two prominent HIV experts discuss the patient's risk for HIV transmission from his husband and from other partners, the magnitude of the risk reduction he would gain with PrEP, and nonpharmacologic alternatives to reduce his likelihood of contracting HIV infection. The patient shares his story in text and on video and explains how his husband's diagnosis affects their relationship both before and after starting PrEP.

All 'Beyond the Guidelines' papers are based on the Department of Medicine Grand Rounds at Beth Israel Deaconess Medical Center in Boston. A list of topics and related videos are available at http://www.annals.org/grandrounds.
-end-
Note: For an embargoed PDF, please contact Cara Graeff. To interview the lead author, please contact Lizzie Williamson at erwillia@bidmc.harvard.edu or 617-632-8217.

American College of Physicians

Related Hiv Infection Articles:

Scientists pinpoint new mechanism that impacts HIV infection
A team of scientists led by Texas Biomed's Assistant Professor Smita Kulkarni, Ph.D. and Mary Carrington, Ph.D., at the Frederick National Laboratory for Cancer Research, published results of a study that pinpointed a long noncoding RNA molecule which influences a key receptor involved in HIV infection and progression of the disease.
HIV: Reprogramming cells to control infection
Following research on cohorts, scientists from the Institut Pasteur have described the characteristics of CD8 immune cells in these 'HIV controller' subjects.
USPSTF recommendation on screening for HIV infection
The US Preventive Services Task Force (USPSTF) recommends screening for HIV infection in adolescents and adults ages 15 to 65; in those younger or older at increased risk of infection; and in all pregnant people.
HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.
HIV vaccine protects non-human primates from infection
New research shows that an experimental HIV vaccine strategy works in non-human primates.
New guidelines for treatment and prevention of HIV infection in adults
Experts have updated recommendations for the use of antiretroviral drugs in the treatment and prevention of HIV infection.
Updated recommendations for treating, preventing HIV infection
A volunteer panel of experts in HIV research and patient care evaluated new data and treatments to update recommendations from the International Antiviral Society-USA for the use of antiretroviral drugs in this special communication article.
Tracking down T cell targets to tamp down HIV infection
Scientists have narrowed in on a group of gut-residing immune cells that might predispose women to increased HIV infection risk and more severe disease.
Two antibodies are better than one for preventing HIV infection
A cocktail of two broadly-neutralizing HIV-1 antibodies (bNAbs) protected primates against infection with a mixed population of HIV viruses -- conditions that mimic real-world transmission -- researchers report.
Novel approach to track HIV infection
Scientists used a novel live-cell fluorescent imaging system that allowed them for the first time to identify individual viral particles associated with HIV infection.
More HIV Infection News and HIV Infection Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Uncharted
There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 2: Every Day is Ignaz Semmelweis Day
It began with a tweet: "EVERY DAY IS IGNAZ SEMMELWEIS DAY." Carl Zimmer – tweet author, acclaimed science writer and friend of the show – tells the story of a mysterious, deadly illness that struck 19th century Vienna, and the ill-fated hero who uncovered its cure ... and gave us our best weapon (so far) against the current global pandemic. This episode was reported and produced with help from Bethel Habte and Latif Nasser. Support Radiolab today at Radiolab.org/donate.